Skip to content
Open access · CC-BY via OpenAlex

CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity

Xiao Liu, Maorong Zhu, Cheng Zou, Zhengcong Cao, Yawen Wang, Guangzhao Yang, Xiaolin Liu, Yuxin Wu, Duo Yu, Dan Zheng, Kuo Zhang, Juan Li, Wangqian Zhang, Shuning Wang, Haozhe Qin

Cell Reports Medicine · 2026

Abstract

Although immunotherapy has transformed the treatment landscape for many types of cancer, its therapeutic efficacy in glioblastoma (GBM) is limited by insufficient antigen presentation and the immunogenic cell exclusion in the tumor microenvironment. Here, we develop a candidate-based CRISPR activation (CRISPRa) functional screen to identify regulators of conventional dendritic cell (cDC)-fate specification. We determine that the transcription factors Zfp366/Znf366, Pu.1, Irf8, and Batf3 (ZPIB) are sufficient to convert GBM cells into cDC-like cells. ZPIB-mediated reprogramming results in global transcriptional and epigenetic remodeling in glioma cells. Single-cell RNA sequencing (scRNA-seq) profiling also reveals efficient and dynamic reprogramming of GBM cells to cDCs in vivo. Moreover, reprogrammed tumor cells remodel the microenvironment and elicit systemic tumor-eradicating and durable antitumor immunity in multiple mouse GBM models. Antitumor immunity elicited by ZPIB-DCs is synergistic with immune checkpoint inhibitors. Finally, we evaluate the clinical applicability of this approach by generating ZPIB-DCs from GBM patients within a humanized model. Our study represents a cellular reprogramming therapeutic strategy with broad implications for clinical immunotherapy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.xcrm.2026.103018
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Liu, X., Zhu, M., Zou, C., Cao, Z., Wang, Y., Yang, G., Liu, X., Wu, Y., Yu, D., Zheng, D., Zhang, K., Li, J., Zhang, W., Wang, S., Qin, H., Hao, Q., Zhang, Y., Yin, A., He, Y., &amp; He, L. (2026). CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity. <em>Cell Reports Medicine</em>. https://doi.org/10.1016/j.xcrm.2026.103018
Vancouver
Liu X, Zhu M, Zou C, Cao Z, Wang Y, Yang G, et al. CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity. Cell Reports Medicine. 2026. doi:10.1016/j.xcrm.2026.103018.
BibTeX
@article{xiao2026CRISPR, title = {CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity}, author = {Xiao Liu and Maorong Zhu and Cheng Zou and Zhengcong Cao and Yawen Wang and Guangzhao Yang and Xiaolin Liu and Yuxin Wu and Duo Yu and Dan Zheng and Kuo Zhang and Juan Li and Wangqian Zhang and Shuning Wang and Haozhe Qin and Qiang Hao and Yingqi Zhang and Anan Yin and Yalong He and Lei He and Xiaonan Luo and Wei Lin and Meng Li and Jintao Gu}, journal = {Cell Reports Medicine}, year = {2026}, doi = {10.1016/j.xcrm.2026.103018}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings